CYTOMX
biochemicals, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen Read More
Classification Information
Class [1]
Chemical Products
Biochemicals, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; diagnostic and therapeutic kits comprising proteolytically-activatable or protease-activatable, proteolytically-activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells, and antigens; immunoglobulin and antigen-binding fragments for drug conjugation and targeted cell binding for laboratory and research use; assays and reagents for use in scientific, laboratory and research purposes; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use.
Class [5]
Pharmaceutical Products
Biological drugs for use in treating cancer, infections, autoimmunity, and inflammation; therapeutic and diagnostic agents and preparations for use in therapies and diagnosis for cancer, infections, autoimmunity, and inflammation; biochemicals, immunoglobulins and antigen-binding fragments for use in therapies and diagnosis for cancer, infections, autoimmunity, and inflammation; engineered cell therapies for medical purposes, namely for use in treating cancer, infections, autoimmunity, and inflammation; therapeutic and diagnostic agents, preparations and substances for medical purposes; immune modulators, immunoglobulin drug conjugates, immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of dysregulated proteolytic activity for medical purposes; immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of cancer, infections, autoimmunity, and inflammation for medical purposes; assays and reagents for use in medical, diagnostic and therapeutic purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery for medical, diagnostic and therapeutic purposes; assay kits comprised of assays and reagents for use in identifying candidate patient populations for specific therapeutic treatments.
Class [42]
Computer & Software Services & Scientific Services
Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy, oncology and dysregulated proteolytic activity; medical and scientific research and development for agents, preparations, products and technology in the field of dysregulated proteolytic activities; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, oncology and dysregulated proteolytic activity; scientific investigations for medical purposes; medical research; providing scientific, diagnostic and medical research information and analysis relating to biochemicals, engineered cell therapies and immunotherapy; proteolytic activation, antibody binding, therapeutic treatments, patient recovery, and the identification of candidate patients for specific therapeutic treatments; testing, research, design and development services in the field of biochemicals for scientific, diagnostic and medical purposes; research, design and development of assays for measuring, monitoring, testing and analyzing proteolytic activation, antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer network.
